1Yr·

Quarterly figures from 13.01.2023...

Today there were first interesting Zahlen⤵️


The quarterly season is now starting again and today there were, in my opinion, the first really interesting quarterly figures. As always, I summarize them briefly for you in this article.


$BLK Blackrock Inc:

Beat analyst estimates of $7.86 in the fourth quarter with earnings per share of $8.93. Revenue of $4.34 billion exceeded expectations of $4.26 billion.


$WFC Wells Fargo & Co:

fourth-quarter earnings per share of $1.37 beat analyst estimates of $1.27. Revenue of $19.66 billion below expectations of $19.99 billion.


Wells Fargo expects fiscal 2023 net interest income to be about ten percent higher than the prior year at $45 billion.


$JPM JPMorgan Chase & Co:

Exceeds analyst estimates of $3, 11 in the fourth quarter with earnings per share of $3.57. Revenue of $34.5 billion above expectations of $34, 17 billion. Investment banking revenue of $1.39 billion (forecast: $1.66 billion).


JPMorgan expects net interest income of about 73 billion dol-lars in fiscal 2023, depending on the market.


$UNH United Health Group:

Health insurance group UnitedHealth beat analysts' expectations for revenue and profit in the fourth quarter. The shares are trading little changed in pre-market. UnitedHealth benefited from falling healthcare costs in the fourth quarter of 2022 and continued to grow. Revenue increased 13% from the year-ago quarter to $82.8 billion, UnitedHealth said Friday before the U.S. stock market open. Analysts had expected slightly less, at $82.6 billion.

Operating profit rose to $6.9 billion from $5.5 billion, while net profit margin increased to 5.8% from 5.5%. Diluted earnings per share increased from $4.26 to $5.03. On an adjusted basis, earnings per share were $5.34, above analysts' estimates of $5.17.

The medical expense ratio, which expresses the relationship between healthcare costs and premium revenue, decreased to 82.8% from 83.7% in the prior year, resulting in an increase in profitability. The pharmacy benefit management business, Optum, grew above average, increasing sales by 16.5% to $47.9 billion. For the full year, revenue increased 13% to $342.2 billion, while operating profit increased from $24.0 billion to $28.4 billion and diluted earnings per share increased from $18.08 to $21.18. On an adjusted basis, earnings per share increased from $19.02 to $22.19. The 2023 guidance published in November was confirmed. Accordingly, it expects sales of $357 billion to $360 billion, earnings per share of $23.15 to $23.65 and adjusted earnings per share of $24.40 to $24.90. The shares hardly reacted to the figures in pre-market trading and were last quoted around 0.3% down at USD 494.00.


#quartalszahlen
#community
#communityfeedback
#zahlen
#wirtschaft
#wirtschaftswachstum
#stockanalysis
#unternehmen
#aktien
#aktiennews
#aktientipps
#boerse
#börse
#news
#newsroom
#wellsfargo
#jpmorgan
#blackrock
#unitedhealth

15

Join the conversation